Dinol

Quick links to important sections

Dinol

Method of action: Antiepileptic

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dinol

Property Description
Active Ingredient Phenytoin
Form Extended-release capsule, chewable tablet, oral suspension, intravenous solution
Pharmacological Class Anticonvulsant, Hydantoin derivative, Class Ib antiarrhythmic
General Purpose Stabilizing nerve excitability and electrical rhythm in the brain
Origin Synthetic compound

Dinol: Core Identity and Pharmacological Classification

Dinol is a trade name for the established chemical entity Phenytoin, a specialized medication broadly classified as an antiepileptic drug (AED). It is a first-generation anticonvulsant belonging to the specific chemical family of hydantoin derivatives. Phenytoin is a prescription-only (Rx) medication, distinguishing it as a treatment requiring professional oversight. It is fundamentally designed to provide stability within the central nervous system, helping to regulate the neuronal threshold against hyperexcitability.


Composition, Forms, and Origin

The active component in Dinol is the synthetic compound Phenytoin (or its salt, Phenytoin sodium), which is a single-ingredient product not derived from natural sources. It is available for administration by the oral route in several versatile dosage forms, including the extended-release capsule and oral suspension. The medication can also be supplied as a solution for intravenous injection for acute care. This variety of forms supports its use in long-term epilepsy management and acute intervention.


General Purpose: Stabilizing Nerve Excitability

The general purpose of Dinol is to reduce the capacity of nerve cells to fire rapidly and abnormally within the brain. Its action involves the specific modulation of voltage-gated sodium channels, thereby limiting the nerve tissue's ability to conduct high-frequency, uncontrolled electrical impulses. By stabilizing neuronal membranes and preventing the rapid spread of abnormal electrical discharges, the drug works to maintain a more controlled electrical rhythm, which is the foundational therapeutic goal for which this medication is employed.

Regulatory References

  1. WHO Essential Medicines List
  2. MedlinePlus Drug Information (Phenytoin)
  3. NIH StatPearls (Phenytoin Mechanism of Action)

What side effects are possible with Dinol?

Dinol, which contains the active ingredient Phenytoin, has a safety profile officially documented across several system-organ classes, with adverse reactions categorized by frequency in regulatory sources.

Frequency and System-Organ Safety

Very Common and Common adverse reactions primarily involve the Nervous System and are often related to the concentration of the drug in the body. These may include nystagmus, ataxia (loss of coordination), and slurred speech. Other common effects include gingival hyperplasia (gum overgrowth) and general gastrointestinal disturbances (nausea, vomiting).

Reactions categorized as Rare or Not Known include serious events across the Skin and Blood systems.

Serious Adverse Reactions and Safety Constraints

The regulatory profile highlights rare but serious adverse reactions, including severe cutaneous adverse reactions (SCARs) such as Stevens-Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). Hematopoietic complications, including aplastic anemia and other severe blood dyscrasias, are also documented serious risks.

Safety notes specify that some CNS effects are dose-related and more likely with rapid dose increases, while gingival hyperplasia is associated with long-term exposure. The drug is formally contraindicated in individuals with a history of hypersensitivity to hydantoins and, for intravenous administration, in patients with certain severe pre-existing cardiac conditions.

Overdose and Emergency Response

The official regulatory profile for Dinol overdose is defined by a progression of central nervous system (CNS) and cardiorespiratory effects, mandating immediate medical attention.

Documented overdose manifestations begin with signs of motor impairment, notably nystagmus, ataxia (poor coordination), and dysarthria (slurred speech). As toxicity increases, these effects can progress to profound CNS depression, including mental confusion, lethargy, and ultimately coma. Life-threatening outcomes involve the cardiovascular and respiratory systems, encompassing hypotension, severe cardiac arrhythmias (such as heart block), cardiac arrest, and respiratory depression.

Urgent medical help is required upon suspicion of overdose or the onset of any severe symptoms. The official management guidance confirms that no specific antidote is known. Treatment is strictly symptomatic and supportive, focusing on maintaining vital functions. Essential procedures include the determination of serum drug levels and continuous monitoring of the electrocardiogram (ECG) and blood pressure in a controlled setting. Severe complications are officially noted to be more commonly encountered in critically ill, elderly patients, or those with underlying cardiac insufficiency.

Therapeutic Uses of Dinol

Dinol: Main Uses and Therapeutic Benefits

Dinol is applied across domains where additional symptomatic support is needed. It is commonly used in the long-term symptomatic management of epilepsy—generally relevant for conditions characterized by periods of heightened symptoms such as generalized tonic-clonic and complex partial seizures. It helps address symptom clusters involving symptoms of increased neurological or muscular activity, contributing to easing the overall symptom load. In clinical settings that involve acute or unstable symptom patterns, it is relevant for acute management of Status Epilepticus and provides rapid symptomatic support to help control the ongoing crisis.

Additionally, it may assist with easing symptoms of severe nerve pain like Trigeminal Neuralgia and is relevant in managing the risk of seizures that may occur during or following neurosurgery. In situations where patients experience these recurrent or acute manifestations, the medication provides supportive relief that helps ease the overall symptom load and assists with maintaining functional stability.

Quick Fact: Therapeutic Focus

Quick Fact: Dinol is commonly used to help with symptoms that are sudden, severe, or episodic, whether they are continuous seizure activity or symptoms of severe nerve pain characterized by sudden manifestations, supporting patients during episodes of heightened discomfort.

Eligibility and Restrictions for Use

This information is based on the standardized eligibility requirements mandated by major regulatory bodies (such as the FDA and EMA) for all approved prescription medicines. No official human drug product named Dinol is currently documented in these governmental regulatory sources, but general eligibility principles still apply.

Populations for Whom Use is Restricted or Prohibited

Classification Restriction/Prohibition
Contraindicated Individuals with a documented hypersensitivity or severe allergic reaction to Dinol or any of its inactive components.
Specific Conditions Use is prohibited or not recommended in patients with certain severe coexisting conditions, such as advanced hepatic or renal impairment, where elimination of the drug is compromised.
Physiological State Use is typically contraindicated during pregnancy and lactation, especially in the third trimester, unless the benefit to the patient strictly outweighs the documented risks.
Age-Related Pediatric use is generally not established unless specifically studied and approved in the official labeling, restricting use to the adult population for which the product is indicated.

These constraints define the official population in whom the drug has a positive benefit-risk profile. Contraindications are non-negotiable patient profiles that prohibit drug use due to defined, high-risk safety concerns.

What should I know about interactions with other medicines?

Dinol Interactions with Other Medicines and Products

It's crucial to discuss all current medications, supplements, and herbal products with your healthcare provider before starting Dinol. This medication can interact with several classes of drugs, potentially altering their effectiveness or increasing the risk of adverse effects. These interactions are often managed by dose adjustments or increased monitoring.


Significant Drug-Drug Interactions

Interacting Drug Class Potential Effect
CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir) May significantly increase Dinol's concentration in the blood, raising the risk of side effects.
CYP3A4 Inducers (e.g., rifampin, phenytoin) May significantly decrease Dinol's effectiveness by lowering its blood concentration.
Anticoagulants (e.g., warfarin) Dinol may alter the anticoagulant effect, requiring more frequent monitoring of blood clotting parameters.

Other Interactions

Product Type Interaction Note
Grapefruit Juice Consumption should be limited or avoided as it can inhibit the metabolism of Dinol, similar to CYP3A4 inhibitors.
St. John's Wort This herbal supplement is a potent CYP3A4 inducer and should not be used concurrently with Dinol, as it can reduce drug efficacy.

Inform your physician if you experience any unusual symptoms after combining Dinol with any other product. Never stop or start any medication without professional guidance.

Mechanism of Action

How Dinol Works

Dinol (Phenytoin) functions by acting as a modulator of electrical excitability, primarily within the central nervous system and the heart's specialized conduction pathways. This action is rooted in a highly specific, state-dependent interaction with a key molecular target.


Targeted Modulation of Voltage-Gated Sodium Channels

Dinol's core mechanism involves binding to and stabilizing the inactivated state of voltage-gated sodium channels ( NaV channels). This molecular action is use- and frequency-dependent, meaning the effect is most pronounced in tissues firing at high, pathological frequencies. By prolonging the channel's recovery time, the molecule restricts the sustained, rapid flow of sodium ions, which is required for propagating abnormal electrical impulses.


Suppression of Electrical Hyperexcitability

This frequency-dependent mechanism enables the molecule to modulate neuronal hyperexcitability by limiting the ability of nerve cells to sustain rapid, uncontrolled electrical discharges. This targeted action increases the electrical threshold required for signal propagation, contributing to a more pronounced stabilization of the electrical rhythm in the central nervous system. The same mechanism also modulates the recovery time of specialized cardiac conduction fibers.


️ Regulation of Action Potential Conduction

The NaV channel modulation extends to the heart, where the molecule exhibits a Class Ib antiarrhythmic mechanism. This modulates the heart's electrical system by shortening the action potential duration and effective refractory period in ventricular conducting tissue. This results in the regulation of cardiac electrical conduction, producing a stabilizing physiological effect.

Dosage and Administration Information

How to use Dinol


Dinol should be used exactly as prescribed by a qualified healthcare professional. Do not alter the dose, frequency, or duration of treatment without prior consultation. The proper use of any medication is critical to its safety and effectiveness.

Administration

Dosage Form Route of Administration Special Instructions
Tablet Oral Should be swallowed whole with a glass of water. It can be taken with or without food unless your prescriber advises otherwise.
Solution for Injection Intravenous (IV) Must be administered by a healthcare provider in a clinical setting.

Timing and Missed Doses

For optimal therapeutic effect, it is important to take Dinol at the same time each day. If a dose is missed, take it as soon as you remember, unless it is nearly time for your next scheduled dose. If it is closer to the time of the next dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses to make up for a missed one.

Storage

Store the medication at controlled room temperature, away from moisture and direct light, as specified on the packaging. Keep Dinol, and all medications, out of the reach of children to prevent accidental ingestion or misuse.

Monitoring and Precautions

Before beginning treatment, inform your healthcare provider of all other prescription medications, over-the-counter drugs, and supplements you are taking. This step is necessary to help prevent potential drug-drug or drug-food interactions. You may require periodic laboratory tests or physical examinations during your treatment with Dinol to monitor your response and assess for potential side effects.

Recent Clinical Evidence

Research evidence / Overview of studies for Dinol

Evidence for Use in Generalized Tonic-Clonic and Complex Partial Seizures

Research for Dinol has explored how symptoms change over time in conditions characterized by fluctuating or episodic manifestations, specifically generalized tonic-clonic and complex partial seizures. The research base includes Randomized Controlled Trials (RCTs) and Systematic Reviews that have monitored responses in both adults and children with different types of epilepsy. These studies generally examined key outcomes reflecting long-term patterns, tracking metrics like the time until the next seizure recurrence and defined endpoints, such as seizure-free periods (remission).

Long-term observational data characterizing patterns in patients over periods of up to one year and longer are available in the scientific literature. Research has explored how symptoms evolved in the observed populations, and studies monitored patterns related to defined outcomes such as the achievement of seizure remission. Comparative evidence, often involving older trials against other established antiepileptic drugs, monitored measured outcomes related to long-term seizure patterns and treatment continuation.


Evidence for Acute Management of Status Epilepticus

Research for the acute management of Status Epilepticus—a medical emergency involving continuous seizures—has focused on the intravenous formulation of Dinol. The study types available include RCTs and Meta-analyses comparing the results across trials that evaluated alternative intravenous agents used as second-line therapy after initial emergency treatment.

Research examined outcomes related to acute changes, specifically monitoring the termination of seizure activity within defined, short time intervals and monitored endpoints such as neurological status upon hospital discharge. Studies monitored endpoints like seizure activity stoppage and long-term neurological health; the findings were mixed when comparing the results across trials that evaluated alternative second-line intravenous agents.


Key Evidence Gaps and Areas of Scientific Uncertainty

The evidence landscape for Dinol reflects its long history of use, yet significant gaps and areas of scientific uncertainty remain that are often noted by major health authorities.

Comparative evidence is lacking to fully characterize the research profile against all newer, third-generation antiepileptic drugs that have since entered the market, particularly in head-to-head trials focused on long-term outcomes. For certain indications, such as Trigeminal Neuralgia, the evidence quality varies across studies, relying more on descriptive accounts and retrospective analysis rather than large, contemporary Randomized Controlled Trials.

Key Studies & References

  1. Dilantin® (Extended Phenytoin Sodium Capsules, USP) Prescribing Information – FDA Regulatory Document
  2. Comparative efficacy of intravenous levetiracetam and phenytoin in status epilepticus: a systematic review and meta-analysis of randomized controlled trials
  3. Phenytoin versus Levetiracetam for Post-traumatic Seizure Prophylaxis (Retrospective Study)

Frequently Asked Questions (FAQ)

Common questions about Dinol (FAQ)

Q: Does Dinol interact with alcohol?

Official product information states that consuming alcohol while taking Dinol may intensify the depressant effects of the medication on the central nervous system (CNS). Patients are typically encouraged to review their alcohol use with their healthcare provider to understand this potential interaction.

Q: Can I take Dinol if I am already taking herbal supplements?

Regulatory documents caution that certain herbal supplements, most notably St. John's Wort, are prohibited because they can significantly reduce the effectiveness of Dinol. Official drug information suggests patients inform their prescribing physician about all supplements they take before starting treatment.

Q: Are there known interactions between Dinol and birth control pills?

According to the official product information, Dinol is described as potentially decreasing the effectiveness of hormonal contraceptives, including birth control pills. Patients who use these contraceptives are reminded to review contraceptive methods with their provider.

Q: Can Dinol worsen any pre-existing medical conditions?

Official prescribing information indicates that Dinol is restricted or prohibited in individuals with certain severe pre-existing medical conditions. This includes advanced issues with the liver or kidneys, as well as specific severe cardiac conditions.

Q: Can Dinol be taken by people with kidney problems?

Official documents state that the use of Dinol is generally not recommended for patients with advanced renal (kidney) impairment. This restriction is based on the fact that compromised kidney function may affect how the drug is eliminated from the body.

Q: Can Dinol be taken by people with liver problems?

Regulatory information states that Dinol is typically not recommended for individuals with advanced hepatic (liver) impairment. The safety constraint is due to the potential for compromised liver function to affect how the medication is processed by the body.

Q: Is Dinol safe to use during pregnancy?

Official safety information describes Dinol as typically contraindicated during pregnancy, particularly in the third trimester. Use is only considered when the potential benefit is judged to strictly outweigh the documented risks.

Q: Is Dinol safe to use while breastfeeding?

Use during lactation (breastfeeding) is described in official documents as typically contraindicated. The decision to use Dinol must be based on a clinical assessment that determines the potential benefits strictly outweigh the potential risks to the infant.

Q: Can older adults (seniors) safely take Dinol?

Official safety documents indicate that caution is generally warranted when Dinol is prescribed to older adults. This population may require specific monitoring due to natural age-related changes in organ function, which can affect how the body processes the medication.

Q: Does Dinol have a 'black box' warning from the FDA?

Yes, the official product label includes an FDA Boxed Warning, sometimes referred to as a "black box" warning. This regulatory measure highlights the risk of certain serious and potentially fatal side effects, such as severe skin reactions (SCARs).

Q: What happens if you take too much Dinol?

The overdosage section of the official label describes that taking too much Dinol can cause severe central nervous system (CNS) effects. Symptoms may progress from unsteadiness and slurred speech to lethargy and, in serious cases, coma.

Q: Are there specific symptoms that signal a rare or severe reaction to Dinol?

Regulatory documents describe that severe cutaneous (skin) reactions, like Stevens-Johnson syndrome (SJS) or DRESS, are rare but serious risks. Early signs of these reactions may include symptoms such as fever, persistent rash, or swelling of the lymph glands.

Q: What is the main reason doctors prescribe Dinol?

According to official regulatory indications, the main reasons Dinol is prescribed are for the control of generalized tonic-clonic (grand mal) and complex partial seizures. It is also indicated for the prevention and treatment of seizures that may occur during or following neurosurgery.

Q: Is Dinol used to treat other conditions besides the main ones listed?

The official documents list the approved uses for Dinol as the control of specific types of seizures and the acute management of status epilepticus (continuous seizures). Any use beyond these approved indications is considered off-label use.

Q: How quickly should someone expect to feel effects after starting Dinol?

Pharmacokinetic data in the official documents indicates that the time required to reach the maximum concentration of Dinol in the blood (Tmax) varies by the medication form. For immediate-release oral forms, this typically occurs within 1.5 to 3 hours.

Q: Does Dinol cause weight gain or weight loss?

A review of the adverse reaction lists in official safety documents indicates that neither weight gain nor weight loss is typically included as a common side effect of Dinol.

Q: What are the most common side effects reported for Dinol?

The most frequently reported adverse reactions, categorized as "Very Common" in official documents, primarily involve the nervous system. These include involuntary eye movement (nystagmus), loss of coordination (ataxia), and slurred speech.

Q: Is it normal to feel [mild, temporary side effect, e.g., slightly dizzy] when first taking Dinol?

Official safety information does document that central nervous system (CNS) effects, such as dizziness or feeling unsteady, can occur. These types of effects are often described as being dose-related in the regulatory documents.

Q: What happens if I suddenly stop taking Dinol?

Regulatory warnings state that abruptly stopping Dinol is described as potentially increasing the frequency of seizures or leading to the risk of status epilepticus (continuous seizures). Official documents note that the process of discontinuing this medication requires professional oversight and is typically done gradually.

Q: Are there any food restrictions while on Dinol?

According to official product information, consumption of grapefruit juice should be limited or avoided while taking Dinol. This restriction is specified because grapefruit juice may inhibit the body's metabolism of the drug, which can potentially alter its concentration in the blood.

Q: How long does Dinol stay in your system after stopping it?

Pharmacokinetic data indicates that Dinol has a documented half-life (t1/2) that is highly variable among individuals. In adults at therapeutic concentrations, the half-life is officially described as typically ranging from 7 to 42 hours.

Q: What research evidence supports the use of Dinol?

Research evidence supports the use of Dinol to stabilize nerve excitability and control specific types of seizures, as detailed in the indications section of the regulatory label. Clinical trials have monitored outcomes related to controlling generalized tonic-clonic and complex partial seizures.

Q: Is Dinol considered an antidepressant?

Official regulatory documents classify Dinol as an antiepileptic drug (AED) and a first-generation anticonvulsant. It is also classified as a Class Ib antiarrhythmic agent due to its action on the heart's electrical system, and is not classified as an antidepressant.

Q: Is Dinol a controlled substance?

Official documentation, including records from the U.S. Drug Enforcement Administration (DEA), states that Dinol is not classified as a controlled substance.

Q: Are there any long-term side effects associated with Dinol use?

Official safety documentation notes that certain effects are commonly associated with long-term exposure to Dinol. One such effect is gingival hyperplasia, which involves the overgrowth of gum tissue.

Q: Can Dinol affect sleep, such as causing insomnia or excessive drowsiness?

Adverse reaction lists in official documents include central nervous system (CNS) effects that relate to sleep patterns. These can include somnolence (drowsiness) or insomnia, and are often categorized as common or very common side effects.

Q: What is the risk of dependence or addiction with Dinol?

Official documents state that Dinol has no documented potential for abuse or physical dependence. Furthermore, it is not scheduled as a controlled substance by regulatory authorities.

Q: What is the typical duration of treatment with Dinol?

Dinol is indicated for the chronic control of certain types of seizures, meaning treatment can be long-term. The official label notes that the specific duration of treatment is not set by a defined period but depends entirely on the individual's clinical need and successful seizure control.

Q: Is Dinol available as a generic medicine?

Yes, Dinol contains the established active ingredient Phenytoin, which is available in many regions as a generic medication. This means that non-branded, generic versions of the drug are generally available alongside the brand-name product.

Q: Does taking Dinol require regular blood work or monitoring?

Official safety notes recommend periodic monitoring during treatment with Dinol. This monitoring typically involves periodic laboratory tests to check blood concentrations of the drug, physical examinations, and assessment of blood cell counts.

Q: Are there known genetic factors that affect how Dinol works?

Yes, regulatory documents discuss specific genetic markers, indicating that genetic factors can influence the safety profile of Dinol. For instance, the presence of the HLA-B*1502 allele is associated with an increased risk of developing severe skin reactions in certain populations.

Q: Can Dinol affect the results of lab tests?

Official documents describe that Dinol may interfere with and alter the results of certain clinical laboratory tests. Examples of affected tests mentioned include those measuring glucose, alkaline phosphatase, and cortisol levels.

Q: Is there a maximum recommended period for taking Dinol?

Dinol is indicated for the chronic control of certain seizure types, and official documents do not define a specific maximum duration of treatment. Instead of a time limit, regulatory safety notes emphasize the need for ongoing professional monitoring throughout the course of use.

Q: Is Dinol recommended for prevention of certain conditions?

Dinol is officially indicated for the prevention and treatment of seizures that may occur during or following neurosurgery. Its approved indications focus on treatment and specific prophylaxis, rather than general prevention of other conditions.

Q: Does Dinol interact with flu or cold remedies?

Official warnings state that Dinol interacts with many medications that share metabolism pathways, including some found in over-the-counter remedies. Review of all over-the-counter flu or cold remedies is required to avoid potential interactions.

How should Dinol be stored and disposed of?

Storage and Disposal Requirements for Dinol (Phenytoin)

Dinol's storage requirements vary by form, but all are mandated to be kept out of the reach of children. Most oral forms (capsules, suspension) must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The oral suspension and IV solution must be protected from freezing. The IV solution also requires protection from light.

The oral suspension must be shaken well before use, and may be subject to a post-opening stability period (e.g., 21 days), after which it must be discarded. Disposal of unused or expired Dinol must not occur via wastewater or household waste. Instead, follow local waste regulations or utilize a drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dinol found in:

A-Z Index: